Dr. Melania Montes, PhD


With a long-standing track record in prostate cancer research, Dr Montes' work has primarily focused on identifying novel biomarkers for detection and prognosis, as well as exploring therapeutic strategies based on gene expression modulation. More recently, her research has shifted to investigating metabolic vulnerabilities in colorectal cancer, with a particular emphasis on how lipid metabolism and oxidative stress can be targeted to enhance therapeutic outcomes.

Cellular and Molecular Biology – Prostate Cancer – Gene Expression Analysis – RT-qPCR – Western Blotting – Cell-Based Assays for Drug Testing – In Vitro Functional Assays – NF-κB Signaling Pathway – Diagnostic and Prognostic Biomarkers – Liquid Biopsies – MicroRNAs – Exosomes

 

Visiting Researcher - UC Berkeley - research focuses on metabolic vulnerabilities in colorectal cancer, with a particular interest in how lipid metabolism and oxidative stress can be leveraged to improve therapeutic strategies.

Education:

Vall d’Hebron Institute of Research (VHIR) - PhD - MicroRNAs as Predictors and Therapy for Prostate Cancer.

Other links:

https://www.linkedin.com/in/melania-montes-ph-d-852b5b41/